PSTV vs UNH

Plus Therapeutics (PSTV) retains its high-risk, high-reward profile, but its immediate financial health has significantly improved since the last analysis. The company's cash position increased to over $16 million in 2025, moving stockholders' equity from negative to positive $3.9 million, substantially extending its cash runway. This addresses the primary financial risk previously identified. Fur...

UnitedHealth Group (UNH) remains a healthcare titan, but its sheer scale and the highly regulated nature of its operations fundamentally limit its 10x growth potential within 3-5 years. The recent Optum Health operating loss of $278M in 2025 (compared to $7.77B income in 2024) is a significant concern, eroding the growth narrative that Optum once provided. Furthermore, the proposed 0.09% Medicare ...